Vertex Pharmaceuticals ( VRTX ) Inc. (NASDAQ: VRTX) will report its first-quarter earnings on Monday. As the company reports after market hours, Wall Street expects $4.32 in EPS and $2.85 billion in revenues.

The stock is up 25.48% over the past year, 24.48% YTD, riding bullish momentum as investors eye Alyftrek and Journavx launch.

Let’s examine the charts for Vertex stock and how it currently compares to Wall Street estimates.

Read Also: Trump’s New Order Targets Drug Pricing Transparency And Medicare Cost Reduction

Vertex Stock Trend Bullish Ahead Of Q1 Earnings

Chart created using Benzinga Pro

Vertex stock is climbing steadily, with its share price of $504.31 cruising above its five, 20 and 50-day exponential moving averages – a setup that keeps the broader trend strongly bullish. Despite a touch of selling pressure, the stock is still flashing bullish technical signals across the board.

The eight-day simple moving average is $500.01, while the 20-day and 50-day simple moving averages are $491.04 and $492.45, respectively – all below the current price, confirming upward momentum. The 200-day simple moving average is further back at $471.59, reinforcing the long-term bullish outlook. Vertex's Moving Average Convergence Divergence (MACD) indicator clocks in at 4, suggesting that bullish momentum remains intact.

Notably, the Relative Strength Index (RSI) is at 57.46 – comfortably neutral. That means while the stock is rising, it's not yet overheating, giving bulls room to run before overbought concerns set in.

Vertex looks technically sound and bullish, but the mild selling pressure hints that bulls may need to stay patient and disciplined on the next leg higher.

Vertex Analysts See Limited Upside

Ratings & Consensus Estimates: The consensus analyst rating on Buy stock stands at a Buy currently with a price target of $511.08. Analyst ratings from Cantor, RBC and BofA imply just a 0.79% upside for Vertex stock, with an average price target of 507.33 per share.

VRTX Stock Price Action: Vertex stock was trading at $505.46 at the time of publication on Monday afternoon.

Read Next:

Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely